» Articles » PMID: 31468114

Prognostic Impact of Intra-field Heterogeneity in Oral Squamous Cell Carcinoma

Overview
Journal Virchows Arch
Date 2019 Aug 31
PMID 31468114
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic heterogeneity displayed by tumour cells (intratumoural heterogeneity, ITH) represents a diagnostic challenge when assessing tumour mutational profile. In oral squamous cell carcinoma (OSCC), ITH may be found both in tumour cells and in adjacent mucosa. Genetic heterogeneity of the adjacent mucosa can be interpreted as evidence of the field cancerization (field heterogeneity, FH). The aim of the study was to investigate the impact of intratumoural and intrafield heterogeneity on locoregional control. Ten OSCC patients (5 recurrent and 5 nonrecurrent) were studied. Multiple areas were sampled from the bulk of the tumour and the adjacent nonneoplastic mucosa. A panel of 10 tumour-specific OSCC driver genes was analysed for each sample and was used to calculate heterogeneity. Values were compared among recurrent and nonrecurrent OSCC. Mutational analysis highlighted that a single tumour sample has limited accuracy in assessing the genetic profiles of tumours. High values of ITH considering shared mutations between specimens were found in both recurrent and non-recurrent OSCC (p = 0.095). On the contrary, the intrafield genetic heterogeneity was significantly less frequently in the non-recurrent OSCC group (p = 0.032). Heterogeneity within each specimen calculated with variant allele frequency confirmed that there was better discrimination between recurrent and nonrecurrent groups using nonneoplastic adjacent mucosa than tumour tissue (p value 0.0006 and 0.0048 respectively). In agreement with the theory of field cancerization, intrafield genetic heterogeneity correlates with a higher risk of developing loco-regional recurrences and second primaries. In order to reduce the ITH effects, analysis of multiple tumour areas should be encouraged.

Citing Articles

The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer.

Krsek A, Baticic L, Braut T, Sotosek V Biomolecules. 2024; 14(8).

PMID: 39199313 PMC: 11352962. DOI: 10.3390/biom14080925.


Laser therapy decreases oral leukoplakia recurrence and boosts patient comfort: a network meta-analysis and systematic review.

Luo R, Wang Y, Li R, Ma Y, Chen H, Zhang J BMC Oral Health. 2024; 24(1):469.

PMID: 38632580 PMC: 11025167. DOI: 10.1186/s12903-024-04179-9.


Prognostic Value of Molecular Intratumor Heterogeneity in Primary Oral Cancer and Its Lymph Node Metastases Assessed by Mass Spectrometry Imaging.

Kurczyk A, Gawin M, Paul P, Chmielik E, Rutkowski T, Pietrowska M Molecules. 2022; 27(17).

PMID: 36080226 PMC: 9458238. DOI: 10.3390/molecules27175458.


Neuroplasticity Mechanisms in Frontal Brain Gliomas: A Preliminary Study.

Mitolo M, Zoli M, Testa C, Morandi L, Rochat M, Zaccagna F Front Neurol. 2022; 13:867048.

PMID: 35720068 PMC: 9204970. DOI: 10.3389/fneur.2022.867048.


Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness.

Ratti S, Marvi M, Mongiorgi S, Obeng E, Rusciano I, Ramazzotti G Cell Mol Life Sci. 2022; 79(4):195.

PMID: 35303162 PMC: 8933313. DOI: 10.1007/s00018-022-04198-1.


References
1.
McGranahan N, Swanton C . Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell. 2015; 27(1):15-26. DOI: 10.1016/j.ccell.2014.12.001. View

2.
Gerlinger M, Rowan A, Horswell S, Math M, Larkin J, Endesfelder D . Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-892. PMC: 4878653. DOI: 10.1056/NEJMoa1113205. View

3.
Mroz E, Rocco J . MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma. Oral Oncol. 2012; 49(3):211-5. PMC: 3570658. DOI: 10.1016/j.oraloncology.2012.09.007. View

4.
Kalia M . Personalized oncology: recent advances and future challenges. Metabolism. 2012; 62 Suppl 1:S11-4. DOI: 10.1016/j.metabol.2012.08.016. View

5.
Tabatabaeifar S, Thomassen M, Larsen M, Larsen S, Kruse T, Sorensen J . The subclonal structure and genomic evolution of oral squamous cell carcinoma revealed by ultra-deep sequencing. Oncotarget. 2017; 8(10):16571-16580. PMC: 5369985. DOI: 10.18632/oncotarget.15014. View